Onyx Pharmaceuticals, Inc.
Oficiālie reģistra dati
0sekotāju
2013dibināts
Par Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
Galvenā mītneCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Dibināts2013
StatussAktīvs
Patenti60 patenti
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Pierakstieties, lai skatītu visus 60 patentus
Pārlūkojiet pilno patentu portfeli ar publikācijas numuriem, datumiem un saimēm.
Ieiet Izveidot kontu ar savu e-pastuTas ir bez maksas
Turpinot, jūs piekrītat Heelky Lietotāja līgumam, Privātuma politikai un Sīkdatņu politikai.
Atsauksmes
Atsauksmju vēl nav. Esat strādājis ar Onyx Pharmaceuticals, Inc.? Esiet pirmais, kas dalās ar pieredzi.
Juridiskā informācija
| Juridiskais nosaukums | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Skatīt GLEIF ↗ |
| Reģistrētā adrese | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Statuss | Aktīvs |
Avoti: GLEIF · atjaunināts 2026. gada 16. Oktobris
Kontakti un saites
Atrašanās vieta
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Vai šis ir jūsu uzņēmums?
Pieprasiet šo lapu bez maksas, lai pievienotu logotipu, produktus, fotoattēlus un vakances un atbildētu uz atsauksmēm.
Pieprasīt šo lapuPievienojieties Heelky, lai veidotu kontaktus, pieņemtu darbā un augtu
Izveidojiet bezmaksas kontu, lai rakstītu cilvēkiem, pieteiktos vakancēm un publicētu misijas.
Pievienoties tagad — tas ir bez maksas